WallStreetZenWallStreetZen

NYSE: BDX
Becton Dickinson & Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BDX

Based on 6 analysts offering 12 month price targets for Becton Dickinson & Co

Min Forecast
$185.00+5.02%
Avg Forecast
$215.33+22.24%
Max Forecast
$261.00+48.16%

Should I buy or sell BDX stock?

Based on 6 analysts offering ratings for Becton Dickinson & Co.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
0 analysts 0%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BDX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BDX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BDX stock forecasts and price targets.

BDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-03
lockedlocked$00.00+00.00%2025-05-22
lockedlocked$00.00+00.00%2025-05-06
lockedlocked$00.00+00.00%2025-05-02
lockedlocked$00.00+00.00%2025-05-02
Barclays
Top 34%
67
Strong BuyMaintains$261.00+48.16%2025-04-07

1 of 1

Forecast return on equity

Is BDX forecast to generate an efficient return?

Company
19.01%
Industry
8.49%
Market
89.46%
BDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BDX forecast to generate an efficient return on assets?

Company
8.81%
Industry
5.19%
BDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BDX earnings per share forecast

What is BDX's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$14.19+173.92%
Avg 2 year Forecast
$14.75+184.73%
Avg 3 year Forecast
$15.93+207.53%
BDX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BDX revenue forecast

What is BDX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$21.8B+4.62%
Avg 2 year Forecast
$22.9B+9.74%
Avg 3 year Forecast
$24.0B+14.9%
BDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BDX earnings growth forecast

How is BDX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
44.95%
Industry
15.45%
Market
15.78%
BDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BDX revenue growth forecast

How is BDX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
4.74%
Industry
10.22%
Market
10.26%
BDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BDX vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BDX$176.16$215.33+22.24%Strong Buy
ALC$87.78$112.50+28.16%Strong Buy
RMD$256.96$265.86+3.46%Buy
WST$222.26$311.25+40.04%Strong Buy
BAX$31.01$36.00+16.09%Hold
View Top Medical Stocks

Becton Dickinson & Co Stock Forecast FAQ

Is Becton Dickinson & Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: BDX) stock is to Strong Buy BDX stock.

Out of 6 analysts, 4 (66.67%) are recommending BDX as a Strong Buy, 0 (0%) are recommending BDX as a Buy, 2 (33.33%) are recommending BDX as a Hold, 0 (0%) are recommending BDX as a Sell, and 0 (0%) are recommending BDX as a Strong Sell.

If you're new to stock investing, here's how to buy Becton Dickinson & Co stock.

What is BDX's earnings growth forecast for 2025-2027?

(NYSE: BDX) Becton Dickinson & Co's forecast annual earnings growth rate of 44.95% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 15.45%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.78%.

Becton Dickinson & Co's earnings in 2025 is $1,498,000,000.On average, 10 Wall Street analysts forecast BDX's earnings for 2025 to be $4,066,672,597, with the lowest BDX earnings forecast at $4,041,164,537, and the highest BDX earnings forecast at $4,104,218,168. On average, 10 Wall Street analysts forecast BDX's earnings for 2026 to be $4,227,172,749, with the lowest BDX earnings forecast at $4,124,280,687, and the highest BDX earnings forecast at $4,502,602,474.

In 2027, BDX is forecast to generate $4,565,656,105 in earnings, with the lowest earnings forecast at $4,448,147,065 and the highest earnings forecast at $4,688,897,293.

What is BDX's revenue growth forecast for 2025-2027?

(NYSE: BDX) Becton Dickinson & Co's forecast annual revenue growth rate of 4.74% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.26%.

Becton Dickinson & Co's revenue in 2025 is $20,867,000,000.On average, 8 Wall Street analysts forecast BDX's revenue for 2025 to be $6,256,896,361,256, with the lowest BDX revenue forecast at $6,248,821,197,366, and the highest BDX revenue forecast at $6,263,805,032,970. On average, 8 Wall Street analysts forecast BDX's revenue for 2026 to be $6,563,140,109,011, with the lowest BDX revenue forecast at $6,535,795,468,856, and the highest BDX revenue forecast at $6,610,886,611,324.

In 2027, BDX is forecast to generate $6,871,824,605,504 in revenue, with the lowest revenue forecast at $6,825,661,609,153 and the highest revenue forecast at $6,943,924,426,392.

What is BDX's forecast return on assets (ROA) for 2025-2028?

(NYSE: BDX) forecast ROA is 8.81%, which is higher than the forecast US Medical Instruments & Supplies industry average of 5.19%.

What is BDX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year BDX price target, the average BDX price target is $215.33, with the highest BDX stock price forecast at $261.00 and the lowest BDX stock price forecast at $185.00.

On average, Wall Street analysts predict that Becton Dickinson & Co's share price could reach $215.33 by Jun 3, 2026. The average Becton Dickinson & Co stock price prediction forecasts a potential upside of 22.24% from the current BDX share price of $176.16.

What is BDX's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: BDX) Becton Dickinson & Co's current Earnings Per Share (EPS) is $5.18. On average, analysts forecast that BDX's EPS will be $14.19 for 2025, with the lowest EPS forecast at $14.10, and the highest EPS forecast at $14.32. On average, analysts forecast that BDX's EPS will be $14.75 for 2026, with the lowest EPS forecast at $14.39, and the highest EPS forecast at $15.71. In 2027, BDX's EPS is forecast to hit $15.93 (min: $15.52, max: $16.36).

What is BDX's forecast return on equity (ROE) for 2025-2028?

(NYSE: BDX) forecast ROE is 19.01%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.